Talk Ecosystem Innovation track
Merck's EMEA Advance Biotech Grant Program
Mon, Nov 9, 2026 · 3:00–4:15 PM CET Ecosystem Innovation Stage, Koelnmesse
About this session
Through their EMEA Advance Biotech Grant Program, Merck recognize standout emerging biotech companies and helps them navigate their path to commercialization. Delivered as a dynamic competition, five selected biotech companies will have the opportunity to pitch their breakthroughs to Merck's Grant representatives and the overall BIO-Europe audience. Finalists: Navira Bio Procavea Biotech Nagene Conveyxo Luna Therapeutics
Speakers
-
Customer Applications Consultant (Emerging Biotech) – UK/Ireland/Nordics · Merck
Other
